Latanea (Latanoprost)

Latanoprost binds to prostaglandin F receptors in the eye, increasing uveoscleral outflow of aqueous humor. This enhanced drainage reduces intra‑ocular pressure, which is the primary therapeutic goal in glaucoma management.

The dosing regimen for Latanea is determined by the prescribing ophthalmologist. Typically, one drop is instilled in the affected eye(s) once daily in the evening, but the exact dose and frequency must follow the prescriber’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Latanea, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanea (latanoprost) belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong intra‑ocular pressure reduction. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often have a more favorable dosing convenience and efficacy profile, though individual response may vary.

Latanea should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from light and moisture, and discard any product that appears discolored or contaminated.

Latanea is applied as a single drop into the conjunctival sac of the affected eye(s) once daily, preferably in the evening. The patient should avoid touching the tip of the bottle to the eye or any other surface to maintain sterility.

Serious risks, though rare, include severe eye inflammation such as uveitis, allergic reactions affecting the eyelids or surrounding skin, macular edema that can impair vision, and sudden loss of vision. Any of these symptoms require immediate medical attention.

Latanea should not be used by individuals with known hypersensitivity to latanoprost or any component of the formulation, and it is contraindicated in patients with active ocular infections or severe inflammation without prior medical clearance.